| 134.00 BATS BZX Real-Time Price As of 12:02pm ET |  +1.52 / +1.15%Today’s Change | 118.62 Today|||52-Week Range 148.32 | -4.09% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $349.9B |
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.Johnson & Johnson One Johnson & Johnson Plaza New Brunswick New Jersey 08933 |
| Other institutional | 36.93% |
| Mutual fund holders | 31.94% |
| Individual stakeholders | 0.17% |
| Alex Gorsky | Chairman & Chief Executive Officer |
| Joseph J. Wolk | Chief Financial Officer & Executive Vice President |
| Michael H. Ullmann | Executive Vice President & General Counsel |
| Peter M. Fasolo | Chief Human Resources Officer & Executive VP |
| Paulus Stoffels | Vice Chairman-Executive Committee |
